PR Newswire (press release) |
FDA Approves Buprenorphine (Probuphine) Implant for Opioid Replacement Therapy
PR Newswire (press release) LOS ANGELES, May 31, 2016 /PRNewswire/ -- Probuphine – a first-of-its-kind buprenorphine implant for use by those dependent on opioids – has received approval from the FDA. The same drug has previously been available both as a pill form and as a film ... FDA approves first long-acting implant for opioid dependence treatment FDA Approves Buprenorphine to Treat Opioid Dependence |
from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNEReaU2zUL4ejl_X4f9vl8DjGj3WQ&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779123926905&ei=9u1QV7j-MZOX3QHsq7GgBg&url=http://www.prnewswire.com/news-releases/fda-approves-buprenorphine-probuphine-implant-for-opioid-replacement-therapy-300276448.html
via IFTTT
No comments:
Post a Comment